组成图示
示意图生成中
传感器类型
—
检测对象
—
检测原理
—
检测灵敏度
—
效应效果
—
传感器的构成
—
中文摘要
—
英文摘要
BACKGROUND: Transdermal biosensors offer a noninvasive, low-cost technology for the assessment of alcohol consumption with broad potential applications in addiction science. Older-generation transdermal devices feature bulky designs and sparse sampling intervals, limiting potential applications for transdermal technology. Recently a new-generation of transdermal device has become available, featuring smartphone connectivity, compact designs, and rapid sampling. Here we present initial laboratory research examining the validity of a new-generation transdermal sensor prototype.
METHODS: Participants were young drinkers administered alcohol (target BAC = .08 %) or no-alcohol in the laboratory. Participants wore transdermal sensors while providing repeated breathalyzer (BrAC) readings. We assessed the association between BrAC (measured BrAC for a specific time point) and eBrAC (BrAC estimated based only on transdermal readings collected in the immediately preceding time interval). Extra-Trees machine learning algorithms, incorporating transdermal time series features as predictors, were used to create eBrAC.
RESULTS: Failure rates for the new-generation prototype sensor were high (16 %-34 %). Among participants with useable new-generation sensor data, models demonstrated strong capabilities for separating drinking from non-drinking episodes, and significant (moderate) ability to differentiate BrAC levels within intoxicated participants. Differences between eBrAC and BrAC were 60 % higher for models based on data from old-generation vs new-generation devices. Model comparisons indicated that both time series analysis and machine learning contributed significantly to final model accuracy.
CONCLUSIONS: Results provide favorable preliminary evidence for the accuracy of real-time BAC estimates from a new-generation sensor. Future research featuring variable alcohol doses and real-world contexts will be required to further validate these devices.